FDA
approval
· 2024-02-01
FDA Approved: TRI-ESTARYLLA — Supplemental Application (Xiromed, LLC.)
Summary
FDA approved a supplemental application for Tri-Estarylla (norgestimate and ethinyl estradiol) from Xiromed, LLC., supporting an additional or updated label for…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TRI-ESTARYLLA (NORGESTIMATE AND ETHINYL ESTRADIOL)